epirubicin has been researched along with Epithelial Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y | 1 |
| Borani, N; Karalök, MA; Keskin, HL; Köse, MF; Özgül, N; Tulunay, HG; Turan, AT; Üreyen, I | 1 |
| Adio, A; Birch, BR; Chueng, A; Cooper, AJ; Lwaleed, BA; Soh, J | 1 |
| Audouin, J; Bain, S; Camilleri-Broët, S; Hardy-Bessard, AC; Le Tourneau, A; Leduc, B; Levrel, O; Orfeuvre, H; Paraiso, D; Pujade-Lauraine, E | 1 |
| Blouin, P; Branchereau, S; Brugières, L; De Kraker, J; Leverger, G; Rubie, H; Tabone, MD | 1 |
| Bergemann, C; Felix, R; Lemke, AJ; Lübbe, A; Riess, H; Senfft von Pilsach, MI | 1 |
| Colombo, N; Fossati, R; Fruscio, R; Garbi, A; Ieda', N; Lissoni, AA; Mangioni, C; Torri, V | 1 |
1 review(s) available for epirubicin and Epithelial Neoplasms
| Article | Year |
|---|---|
Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Epirubicin; Hepatoblastoma; Humans; Infant; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Prospective Studies; Survival Rate; Treatment Outcome | 2004 |
2 trial(s) available for epirubicin and Epithelial Neoplasms
| Article | Year |
|---|---|
MRI after magnetic drug targeting in patients with advanced solid malignant tumors.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Contrast Media; Drug Delivery Systems; Epirubicin; Female; Ferrosoferric Oxide; Humans; Iron; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Neoplasms, Connective and Soft Tissue; Neoplasms, Glandular and Epithelial; Oxides; Prospective Studies; Reproducibility of Results | 2004 |
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Epirubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Survival Rate; Time Factors | 2008 |
4 other study(ies) available for epirubicin and Epithelial Neoplasms
| Article | Year |
|---|---|
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer.
Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cytoreduction Surgical Procedures; Disease-Free Survival; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Young Adult | 2014 |
Fourier transform infrared spectroscopy imaging of live epithelial cancer cells under non-aqueous media.
Topics: Caco-2 Cells; Calcium Fluoride; Cell Adhesion; Cell Survival; Epirubicin; Epithelial Cells; Equipment Design; Humans; Mineral Oil; Neoplasms, Glandular and Epithelial; Oils; Paraffin; Spectroscopy, Fourier Transform Infrared; Tetrazolium Salts; Thiazoles; Time Factors | 2013 |
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Epirubicin; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Analysis | 2004 |